Scholars Central

EditorialPublished 26 May 2021

Angiotensin II

Authors: Kalyan Kumar Vaddi

Journal of Kidney

Volume 7 · Issue 5 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Angiotensin is a peptide endocrine chemical and a significant piece of the renin-angiotensin-aldosterone framework, a between related endocrine framework significant in volume and circulatory strain control. Angiotensinogen, an alpha-globulin, and the peptide prohormone is blended basically by the liver and courses in plasma. Angiotensin II (AT-II) has as of late got FDA endorsement for use in patients in stun. This action audits the signs, contraindications, action, unfriendly occasions, and other key components of AT-II treatment in the clinical setting as identifies with the fundamental focuses required by individuals from an interprofessional group dealing with the consideration of patients giving stun.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Kidney.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Kidney
  • SubjectNephrology & Urology
  • BylineArticles whose byline prints “Kalyan Kumar Vaddi”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels